BioRestorative Therapies, Inc. announced that Edward Field has been appointed as President of the company's brtxDISC Division. He previously served as the Executive Vice President and Chief Operating Officer of Cytomedix, Inc. and President and COO of Aldagen, Inc. He was also the President/CEO of two biotechnology companies focused on the development of therapeutics in the cardiovascular, cancer and respiratory disease areas.